Angiodynamics (ANGO) Current Deferred Revenue (2012 - 2014)

Angiodynamics has reported Current Deferred Revenue for 3 years, with the latest figure at $1.5 million in Q1 2014.

• For the quarter ending Q1 2014, Current Deferred Revenue fell 60.19% year-over-year to $1.5 million; the trailing twelve-month figure through Feb 2014 stood at $1.5 million (down 60.19% YoY), and the FY2013 full-year result was $1.6 million, down 49.87% from the prior year.
• Current Deferred Revenue for Q1 2014 stood at $1.5 million, down from $1.6 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $3.7 million in Q1 2013, with the low at $1.5 million in Q1 2014.
• Historically, Current Deferred Revenue has averaged $2.4 million across 3 years, with a median of $2.3 million in 2012.
• Annual changes were most pronounced in 2013 — Current Deferred Revenue tumbled 45.35% — and 2014, when it sank 60.19%.
• Angiodynamics' Current Deferred Revenue stood at $3.0 million in 2012, then plunged by 45.35% to $1.6 million in 2013, then declined by 8.97% to $1.5 million in 2014.
• The last three Current Deferred Revenue figures came in at $1.5 million (Q1 2014), $1.6 million (Q4 2013), and $1.6 million (Q3 2013), per Business Quant data.